Acute Endophthalmitis in Eyes Treated Prophylactically with Gatifloxacin and Moxifloxacin

American Journal of Ophthalmology

Volumn 142, Issue 5, 2006, Pages

  Deramo, Vincent A ^a,b   Lai, James C ^a,b   Fastenberg, David M ^a,b   Udell, Ira J ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b Long Island Vitreoretinal Consultants   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEPHALOSPORINASE; CIPROFLOXACIN; GATIFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; NEOMYCIN; OFLOXACIN; POLYMYXIN B; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; CATARACT EXTRACTION; CLINICAL ARTICLE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; ENDOPHTHALMITIS; FEMALE; FOLLOW UP; GRAM POSITIVE BACTERIUM; HAND MOVEMENT; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; VISUAL ACUITY;

EID: 33750046630     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2006.05.044     Document Type: Article

References (17)

1. Taban M., Behrens A., Newcomb R.L., et al. Acute endophthalmitis following cataract surgery: a systematic review of the literature. Arch Ophthalmol 123 (2005) 613-620
2. Mather R., Karenchak L.M., Romanowski E.G., and Kowalski R.P. Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics. Am J Ophthalmol 133 (2002) 463-466
3. Kowalski R.P., Dhaliwal D.K., Karenchak L.M., et al. Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates. Am J Ophthalmol 136 (2003) 500-505
4. Kunimoto D.Y., Sharma S., Garg P., and Rao G.N. In vitro susceptibility of bacterial keratitis pathogens to ciprofloxacin. Emerging resistance. Ophthalmology 106 (1999) 80-85
5. Goldstein M.H., Kowalski R.P., and Gordon Y.J. Emerging fluoroquinolone resistance in bacterial keratitis: a five-year review. Ophthalmology 106 (1999) 1313-1318
6. Alexandrakis G., Alfonso E.C., and Miller D. Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones. Ophthalmology 107 (2000) 1497-1502
7. Kowalski R.P., Pandya A.N., Karenchak L.M., et al. An in vitro resistance study of levofloxacin, ciprofloxacin, and ofloxacin using keratitis isolates of Staphylococcus aureus and Pseudomonas aeruginosa. Ophthalmology 108 (2001) 1826-1829
8. Marangon F.B., Miller D., Muallem M.S., et al. Ciprofloxacin and levofloxacin resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis. Am J Ophthalmol 137 (2004) 453-458
9. Kotlus B.S., Wymbs R.A., Vellozzi E.M., and Udell I.J. In vitro activity of fluoroquinolones, vancomycin, and gentamicin against methicillin-resistant Staphylococcus aureus (MRSA) ocular isolates. Am J Ophthalmol 142 (2006) 726-729
10. Endophthalmitis Vitrectomy Study Group. Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol 113 (1995) 1479-1496
11. Ciulla T.A., Starr M.B., and Masket S. Bacterial endophthalmitis prophylaxis for cataract surgery: an evidence-based update. Ophthalmology 109 (2002) 13-24
12. Kowalski R.P., Romanowski E.G., Mah F.S., et al. Topical prophylaxis with moxifloxacin prevents endophthalmitis in a rabbit model. Am J Ophthalmol 138 (2004) 33-37
13. Moshirfar M., Marx D.P., and Mirzaian G. Endophthalmitis in patients using fourth-generation fluoroquinolones following phacoemulsification. J Cataract Refract Surg 31 (2005) 1669-1670
14. Miller D., Flynn P.M., Scott I.U., et al. In vitro fluoroquinolone resistance in staphylococcal endophthalmitis isolates. Arch Ophthalmol 124 (2006) 479-483
15. Blondeau J.M. Fluoroquinolones: mechanisms of action, classification, and development of resistance. Surv Ophthalmol 49 (2004) S73-S78
16. Hariprasad S.M., Blinder K.J., Shah G.K., et al. Penetration pharmacokinetics of topically administered 0.5% moxifloxacin ophthalmic solution in human aqueous and vitreous. Arch Ophthalmol 123 (2005) 39-44
17. Solomon R., Donnenfeld E.D., Perry H.D., et al. Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5%, and ciprofloxacin 0.3% into the aqueous humor. Ophthalmology 112 (2005) 466-469